Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2. (Q44083591)
Jump to navigation
Jump to search
scientific article published in July 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2. |
scientific article published in July 2002 |
Statements
Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2. (English)
1 reference
Yuji Shimamoto
1 reference
Katsuhisa Koizumi
1 reference
Hiroyuki Okabe
1 reference
Hiromi Kazuno
1 reference
Yuko Murakami
1 reference
Fumio Nakagawa
1 reference
Akira Matsuda
1 reference
Takuma Sasaki
1 reference
Masakazu Fukushima
1 reference
1 July 2002
1 reference
93
1 reference
7
1 reference
825-833
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference